February 10, 2026

Veradermics concludes enrolment in second Phase III VDPHL01 trial

​Veradermics has completed enrolment in its second pivotal Phase III clinical trial of VDPHL01 for male pattern hair loss treatment.The...

February 10, 2026

Takeda and Iambic announce $1.7bn deal to advance small molecule programmes

​Takeda has entered into a multi-year partnership to utilise Iambic’s AI drug discovery models for advancing small molecule programmes, in...

February 9, 2026

Abbott reports positive VERITAS study results for AFib

​Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 LAA occluder, designed to lower...

February 9, 2026

Genentech reports fenebrutinib Phase III results for PPMS

​Genentech has reported new data from the Phase III FENtrepid trial of fenebrutinib, an investigational Bruton’s tyrosine kinase inhibitor, for...

February 9, 2026

Novartis starts construction on new research facility in San Diego, US

​Novartis has commenced construction on its new global Biomedical Research centre in San Diego, California, US, aimed at expanding its...

February 6, 2026

FDA grants clearance for Eyas Medical Imaging’s neonatal MRI system

​The US FDA has granted 510(k) clearance for Eyas Medical Imaging’ Ascent3T neonatal MRI system, a device engineered specifically for...

February 6, 2026

TransCode and Quantum Leap seek FDA approval for Phase IIa TTX-MC138 trial

​TransCode Therapeutics, in partnership with Quantum Leap Healthcare Collaborative, has submitted an IND application amendment seeking approval from the US...

February 6, 2026

Apotex and Grünenthal sign deal for Nebido Canadian distribution

​Apotex and Grünenthal have finalised a licensing agreement granting Apotex exclusive Canadian rights to Nebido, a long-acting injectable testosterone undecanoate...

February 5, 2026

Hologic’s Aptima assay secures FDA approval for HPV primary screening

​Hologic has received FDA approval for its Aptima HPV assay for use in clinician-collected primary screening.The post Hologic’s Aptima assay...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.